1 |
CH0113817123 |
Bellevue Biotech DT CHF |
-3,39 % |
+18,82 % |
-0,31 |
2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-4,23 % |
+18,50 % |
-0,36 |
3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-4,45 % |
+18,48 % |
-0,37 |
4 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-4,54 % |
+18,33 % |
-0,38 |
5 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-4,64 % |
+18,29 % |
-0,38 |
|
39 |
LU1897414303 |
Janus Henderson Horizon Biotechnology Fund A2 USD |
-13,59 % |
+24,29 % |
-0,66 |
|
73 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-9,68 % |
+12,34 % |
-0,98 |
74 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-8,40 % |
+10,70 % |
-1,01 |
75 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-10,31 % |
+12,34 % |
-1,03 |
76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-34,96 % |
+30,36 % |
-1,23 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-35,10 % |
+30,34 % |
-1,23 |